167 related articles for article (PubMed ID: 19915070)
1. TVP1022 protects neonatal rat ventricular myocytes against doxorubicin-induced functional derangements.
Berdichevski A; Meiry G; Milman F; Reiter I; Sedan O; Eliyahu S; Duffy HS; Youdim MB; Binah O
J Pharmacol Exp Ther; 2010 Feb; 332(2):413-20. PubMed ID: 19915070
[TBL] [Abstract][Full Text] [Related]
2. TVP1022 and propargylamine protect neonatal rat ventricular myocytes against doxorubicin-induced and serum starvation-induced cardiotoxicity.
Kleiner Y; Bar-Am O; Amit T; Berdichevski A; Liani E; Maor G; Reiter I; Youdim MB; Binah O
J Cardiovasc Pharmacol; 2008 Sep; 52(3):268-77. PubMed ID: 18806608
[TBL] [Abstract][Full Text] [Related]
3. I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline.
Barac YD; Bar-Am O; Liani E; Amit T; Frolov L; Ovcharenko E; Angel I; Youdim MB; Binah O
PLoS One; 2012; 7(11):e47890. PubMed ID: 23166584
[TBL] [Abstract][Full Text] [Related]
4. TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failure.
Abassi ZA; Barac YD; Kostin S; Roguin A; Ovcharenko E; Awad H; Blank A; Bar-Am O; Amit T; Schaper J; Youdim M; Binah O
Circ Heart Fail; 2011 Jul; 4(4):463-73. PubMed ID: 21558446
[TBL] [Abstract][Full Text] [Related]
5. The cardioprotective efficacy of TVP1022 in a rat model of ischaemia/reperfusion.
Ertracht O; Liani E; Bachner-Hinenzon N; Bar-Am O; Frolov L; Ovcharenko E; Awad H; Blum S; Barac Y; Amit T; Adam D; Youdim M; Binah O
Br J Pharmacol; 2011 Jun; 163(4):755-69. PubMed ID: 21323905
[TBL] [Abstract][Full Text] [Related]
6. TVP1022: A Novel Cardioprotective Drug Attenuates Left Ventricular Remodeling After Ischemia/Reperfusion in Pigs.
Malka A; Meerkin D; Barac YD; Malits E; Bachner-Hinenzon N; Carasso S; Ertracht O; Angel I; Shofti R; Youdim M; Abassi Z; Binah O
J Cardiovasc Pharmacol; 2015 Aug; 66(2):214-22. PubMed ID: 25900266
[TBL] [Abstract][Full Text] [Related]
7. Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro.
Xiao J; Sun GB; Sun B; Wu Y; He L; Wang X; Chen RC; Cao L; Ren XY; Sun XB
Toxicology; 2012 Feb; 292(1):53-62. PubMed ID: 22155320
[TBL] [Abstract][Full Text] [Related]
8. The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
Abou El Hassan MA; Heijn M; Rabelink MJ; van der Vijgh WJ; Bast A; Hoeben RC
Cancer Gene Ther; 2003 Apr; 10(4):270-7. PubMed ID: 12679799
[TBL] [Abstract][Full Text] [Related]
9. Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition.
Youdim MB; Bar Am O; Yogev-Falach M; Weinreb O; Maruyama W; Naoi M; Amit T
J Neurosci Res; 2005 Jan 1-15; 79(1-2):172-9. PubMed ID: 15573406
[TBL] [Abstract][Full Text] [Related]
10. Salvianolic acid B attenuates doxorubicin-induced ER stress by inhibiting TRPC3 and TRPC6 mediated Ca
Chen RC; Sun GB; Ye JX; Wang J; Zhang MD; Sun XB
Toxicol Lett; 2017 Jul; 276():21-30. PubMed ID: 28495616
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate].
Youdim MB; Weinstock M
Cell Mol Neurobiol; 2001 Dec; 21(6):555-73. PubMed ID: 12043833
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives.
Mandel S; Weinreb O; Amit T; Youdim MB
Brain Res Brain Res Rev; 2005 Apr; 48(2):379-87. PubMed ID: 15850677
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer of connexin43 mutants attenuates coupling in cardiomyocytes: novel basis for modulation of cardiac conduction by gene therapy.
Kizana E; Chang CY; Cingolani E; Ramirez-Correa GA; Sekar RB; Abraham MR; Ginn SL; Tung L; Alexander IE; Marbán E
Circ Res; 2007 Jun; 100(11):1597-604. PubMed ID: 17495226
[TBL] [Abstract][Full Text] [Related]
14. Trimetazidine protects cardiomyocytes against hypoxia-induced injury through ameliorates calcium homeostasis.
Wei J; Xu H; Shi L; Tong J; Zhang J
Chem Biol Interact; 2015 Jul; 236():47-56. PubMed ID: 25937560
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with insulin-like growth factor I enhances myocyte contraction by upregulation of Akt-SERCA2a signaling pathway.
Kim SJ; Abdellatif M; Koul S; Crystal GJ
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H130-5. PubMed ID: 18456736
[TBL] [Abstract][Full Text] [Related]
16. An angiotensin-converting enzyme inhibitor protects against doxorubicin-induced impairment of calcium handling in neonatal rat cardiac myocytes.
Maeda A; Honda M; Kuramochi T; Tanaka K; Takabatake T
Clin Exp Pharmacol Physiol; 1997; 24(9-10):720-6. PubMed ID: 9315376
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxic Effects of Short-Term Doxorubicin Administration: Involvement of Connexin 43 in Calcium Impairment.
Pecoraro M; Rodríguez-Sinovas A; Marzocco S; Ciccarelli M; Iaccarino G; Pinto A; Popolo A
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29019935
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid induced leucine zipper inhibits apoptosis of cardiomyocytes by doxorubicin.
Aguilar D; Strom J; Chen QM
Toxicol Appl Pharmacol; 2014 Apr; 276(1):55-62. PubMed ID: 24480152
[TBL] [Abstract][Full Text] [Related]
19. Na+/H+ exchanger inhibitor cariporide attenuates the mitochondrial Ca2+ overload and PTP opening.
Toda T; Kadono T; Hoshiai M; Eguchi Y; Nakazawa S; Nakazawa H; Higashijima N; Ishida H
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3517-23. PubMed ID: 17906113
[TBL] [Abstract][Full Text] [Related]
20. A QSAR study that compares the ability of bisdioxopiperazine analogs of the doxorubicin cardioprotective agent dexrazoxane (ICRF-187) to protect myocytes with DNA topoisomerase II inhibition.
Hasinoff BB; Patel D; Wu X
Toxicol Appl Pharmacol; 2020 Jul; 399():115038. PubMed ID: 32417440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
